(Q47738773)

5 February 2018

title

Hepatitis B vaccination targeted at behavioural risk groups in the Netherlands: does it work? (English)

1 reference

5 February 2018

main subject

Netherlands

0 references

author

Jan Hendrik Richardus

8

object named as

J H Richardus

1 reference

5 February 2018

author name string

R van Houdt

1

1 reference

5 February 2018

F D H Koedijk

2

1 reference

5 February 2018

S M Bruisten

3

1 reference

5 February 2018

E L M Op de Coul

4

1 reference

5 February 2018

M L A Heijnen

5

1 reference

5 February 2018

Q Waldhober

6

1 reference

5 February 2018

I K Veldhuijzen

7

1 reference

5 February 2018

M Schutten

9

1 reference

5 February 2018

G J J van Doornum

10

1 reference

5 February 2018

R A de Man

11

1 reference

5 February 2018

S J Hahné

12

1 reference

5 February 2018

R A Coutinho

13

1 reference

5 February 2018

H J Boot

14

1 reference

5 February 2018

language of work or name

English

0 references

publication date

16 April 2009

1 reference

5 February 2018

published in

Vaccine

1 reference

5 February 2018

volume

27

1 reference

5 February 2018

issue

27

1 reference

5 February 2018

page(s)

3530-3535

1 reference

5 February 2018

High impact of migration on the prevalence of chronic hepatitis B in the Netherlands

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.072

Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.072

Results of an enhanced-outreach programme of hepatitis B vaccination in the Netherlands (1998-2000) among men who have sex with men, hard drug users, sex workers and heterosexual persons with multiple partners

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.072

Impact of a targeted hepatitis B vaccination program in Amsterdam, The Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.072

Molecular epidemiology of acute hepatitis B in the Netherlands in 2004: nationwide survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.072

MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.072

Molecular epidemiology of hepatitis B virus infections in Denmark

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.072

Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.072

Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-year prospective cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.072

Acute hepatitis B virus infection by genotype F despite successful vaccination in an immune-competent German patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.072

Social-cognitive determinants of vaccination behavior against hepatitis B: an assessment among men who have sex with men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.072

Why do gay men want to be vaccinated against hepatitis B? An assessment of psychosocial determinants of vaccination intention.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.072

Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11-15 years: a randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.072

Model based analysis of hepatitis B vaccination strategies in the Netherlands.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.072

10.1016/J.VACCINE.2009.03.072

7 January 2021

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018